ARTICLE | Distillery Therapeutics
Infectious disease
January 9, 2018 10:05 PM UTC
Cell culture and mouse studies suggest inhibiting Candida MIR1 could help treat azole-resistant oropharyngeal candidiasis. In azole-resistant strains of C. albicans isolated from an HIV-infected patie...
BCIQ Company Profiles
BCIQ Target Profiles